Please select your view
Dr Bulliard graduated from the University of New South Wales in 1998. In 2003 Dr Bulliard began specialist training in Anatomical Pathology while based at Westmead Hospital. In 2008 he obtained his Fellowship from the Royal College of Pathologists of Australasia and later joined Australian Clinical Labs as an Anatomical Pathologist participating in all aspects of histopathology and cytology. Dr Bulliard is also committed to the registrar training program at Australian Clinical Labs.
Dr Barnes has joined Clinical Labs in the newly created role of National Director of Haematology and will provide strategic direction nationally for haematology at Clinical Labs. Dr Barnes is a clinical and laboratory trained haematologist who has been part of Melbourne Haematology and has worked with Clinical Labs for several years. Dr Barnes works at the Royal Children’s Hospital and is director of the Haemophilia Treatment Centre. He has experience in both management and leadership positions. Dr Barnes has an active clinical research interest and is also director of Melbourne Haematology (Clinical) and Melbourne Paediatric Specialists
Dr Sudha Pottumarthy-Boddu comes to us from Houston, Texas, where she was Assistant Professor in the Department of Pathology and Laboratory Medicine at the University of Texas, School of Medicine. She was also the Technical Director of the Clinical Laboratory Services at the Houston Department of Health and Human Services. After graduating from medical school in India, Dr Pottumarthy-Boddu migrated to New Zealand and completed her Pathology/Microbiology Fellowship training with the Royal College of Pathologists of Australasia.
She is a recipient of various awards and scholarships, including the Neil Prentice Memorial Prize of RCPA. She has experience in various hospital, research and public health laboratories in the US, publishing over 30 articles in peer-reviewed journals and presenting at various national and international Conferences. Dr Pottumarthy-Boddu's main research interests are antimicrobial susceptibility trends and molecular methods in the diagnosis of infectious diseases.
Dr. Linda Dreyer completed her undergraduate studies in 1996, receiving a Bachelor’s degree in Medicine and Surgery (MBChB) from the Faculty of Health Sciences, University of Pretoria, South Africa. Following four years of clinical practice, as Medical Officer in the Department of Family Medicine she commenced specialisation in 2000.
Dr Dreyer received her Master’s degree in Clinical Microbiology (MMed (Path)) from the University of Pretoria in 2006. She came to Melbourne and joined Australian Clinical Labs in 2008 as a Senior Registrar and obtained Fellowship of The Royal College of Pathologists of Australasia (FRCPA) in 2010. Dr Dreyer has special interests in the appropriate use of antimicrobials, infection control and molecular diagnostic assays in contemporary clinical microbiology.
Dr Travis Brown obtained his MBBS from the Australian National University (ANU) in Canberra. After completing two years as a junior doctor at St Vincent Hospital in Melbourne, he undertook Anatomical Pathology training at Ballarat Base Hospital and the Royal Melbourne Hospital before transferring to General Pathology Specialty training with Healthscope Pathology (now Australian Clinical Labs) in Clayton, Melbourne. Before studying medicine, Travis completed Bachelor of Commerce/Bachelor of Computing degrees at the University of Ballarat and worked for two years in the Global Risk Management Services (Information Technology) department with PricewaterhouseCoopers in Melbourne. He also completed a Bachelor of Science (Medical Sciences) at La Trobe University in Melbourne before entering graduate entry medicine at Canberra.
Dr Brown completed General Pathology Specialty training in November 2016 and is currently working in Wayville, Adelaide with Australian Clinical Labs. He enjoys the diversity that general pathology provides working in biochemistry, microbiology, haematology and anatomical pathology. Dr Brown also has a special interest in Information Technology and Pathology Informatics.
An early diagnosis can determine the correct medical course of action.
New partnership with Garvan Institute of Medical Research to grow clinical genomics capability
New Australian partnership forms to bring world’s first non-invasive melanoma test to market